News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
451,197 Results
Type
Article (21615)
Company Profile (79)
Press Release (429503)
Section
Business (136701)
Career Advice (1332)
Deals (27247)
Drug Delivery (57)
Drug Development (52927)
Employer Resources (117)
FDA (10491)
Job Trends (10237)
News (231607)
Policy (22357)
Tag
Academia (1642)
Alliances (31361)
Alzheimer's disease (904)
Approvals (10461)
Artificial intelligence (98)
Bankruptcy (215)
Best Places to Work (8558)
Breast cancer (158)
Cancer (1042)
Cardiovascular disease (80)
Career advice (1122)
Cell therapy (198)
Clinical research (42627)
Collaboration (342)
Compensation (126)
COVID-19 (1780)
C-suite (82)
Cystic fibrosis (70)
Data (1067)
Diabetes (123)
Diagnostics (4521)
Earnings (57784)
Employer resources (105)
Events (67920)
Executive appointments (303)
FDA (11006)
Funding (283)
Gene therapy (118)
GLP-1 (341)
Government (3525)
Healthcare (13243)
Infectious disease (1851)
Interviews (173)
IPO (14198)
Job creations (2039)
Job search strategy (986)
Layoffs (229)
Legal (5044)
Lung cancer (139)
Lymphoma (77)
Manufacturing (117)
Medical device (9217)
Medtech (9220)
Mergers & acquisitions (13250)
Metabolic disorders (291)
Neuroscience (1124)
NextGen Class of 2024 (4177)
Non-profit (3219)
Northern California (1239)
Obesity (148)
Opinion (143)
Patents (70)
People (40190)
Phase I (12344)
Phase II (18709)
Phase III (15083)
Pipeline (429)
Postmarket research (1685)
Preclinical (5314)
Press Release (69)
Radiopharmaceuticals (179)
Rare diseases (195)
Real estate (3252)
Regulatory (14874)
Research institute (1412)
Resumes & cover letters (216)
Southern California (1022)
Startups (2102)
United States (10626)
Vaccines (333)
Weight loss (91)
Date
Last 7 days (120)
Last 30 days (1482)
Last 365 days (25337)
2024 (25337)
2023 (29158)
2022 (37806)
2021 (41012)
2020 (39513)
2019 (32546)
2018 (24569)
2017 (22275)
2016 (20575)
2015 (25049)
2014 (18753)
2013 (15043)
2012 (15942)
2011 (16479)
2010 (15209)
Location
Africa (513)
Arizona (97)
Asia (24649)
Australia (4008)
California (2693)
Canada (1216)
China (196)
Colorado (117)
Connecticut (135)
Europe (57452)
Florida (359)
Georgia (81)
Illinois (252)
Indiana (146)
Japan (73)
Maryland (473)
Massachusetts (2002)
Michigan (102)
Minnesota (194)
New Jersey (844)
New York (826)
North Carolina (514)
Northern California (1239)
Ohio (94)
Pennsylvania (634)
South America (689)
Southern California (1022)
Texas (380)
Washington State (309)
451,197 Results for "maps public benefit corp".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
MAPS Public Benefit Corporation Announces Oversubscribed Series A Financing and Renames to Lykos Therapeutics
MAPS Public Benefit Corp (“MAPS PBC”), a company dedicated to transforming mental healthcare, announced an oversubscribed Series A financing. MAPS PBC raised more than $100 million including conversion of previously issued convertible notes.
January 5, 2024
·
7 min read
BioMidwest
MMS Supported MAPS Public Benefit Corporation NDA Submitted to FDA for First Psychedelic-Assisted Therapy for PTSD
MMS announced MAPS Public Benefit Corporation (MAPS PBC) submitted a New Drug Application (NDA) to the FDA for MDMA (midomafetamine capsules) used in combination with psychological intervention, which includes psychotherapy, or talk therapy, and other supportive services provided by a qualified healthcare provider.
December 13, 2023
·
2 min read
Press Releases
Anteris Technologies Global Corp. Announces Pricing of U.S. Initial Public Offering
December 13, 2024
·
5 min read
Press Releases
Anteris Technologies Global Corp. Announces Launch of U.S. Initial Public Offering
December 9, 2024
·
5 min read
Press Releases
Agendia Announces Publication Validating MammaPrint® Utility in Prediction of Extended Endocrine Therapy Benefit
December 2, 2024
·
6 min read
Press Releases
CORRECTING and REPLACING Publication in NPJ Vaccines Highlights Benefits of Stratis® Intramuscular Delivery of DNA Vaccine for Hantaviruses
December 11, 2024
·
5 min read
Press Releases
Phio Pharmaceuticals Announces Publication in Frontiers in Immunology
Journal is the official publication of the International Union of Immunological Societies
December 12, 2024
·
4 min read
Biotech Bay
Lykos Therapeutics (Formerly MAPS PBC) Announces Publication Examining the Effects of MDMA-Assisted Therapy on Emotional Coping Skills and Self-Experience in PTSD
Lykos Therapeutics (formerly MAPS Public Benefit Corporation) (“Lykos”) announced that PLOS ONE has published the first comparison of the effects of investigational MDMA-assisted therapy and therapy with placebo on emotional coping skills and self-experience in adults with severe post-traumatic stress disorder (“PTSD”).
January 10, 2024
·
9 min read
Bio NC
United Therapeutics Issues its 2023 Corporate Responsibility and Public Benefit Report
United Therapeutics Corporation, a public benefit corporation, announced the release of its 2023 Corporate Responsibility and Public Benefit Report covering its 2022 progress toward its public benefit goals and objectives and summarizing its efforts to advance the interests of its patients and other stakeholders.
September 12, 2023
·
4 min read
Genetown
T2 Biosystems Announces New Publication Highlighting the Clinical Benefits and Performance of the T2Resistance Panel
T2 Biosystems, Inc. today announced the publication of a new study highlighting the clinical benefits and performance of real-world use of the T2Resistance® Panel in The Journal of Clinical Microbiology.
March 18, 2024
·
5 min read
1 of 45,120
Next
